(Q3)Jul 31, 2020 | (Q2)Apr 30, 2020 | (Q1)Jan 31, 2020 | (FY)Oct 31, 2019 | (Q4)Oct 31, 2019 | (Q3)Jul 31, 2019 | (Q2)Apr 30, 2019 | (Q1)Jan 31, 2019 | (FY)Oct 31, 2018 | (Q4)Oct 31, 2018 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -283.63%-2.63M | -886.15%-1.09M | 88.87%-194.05K | 34.82%-2.86M | 81.78%-366.59K | -187.26%-684.54K | 90.94%-110.32K | 7.79%-1.74M | -408.78%-4.39M | -285.46%-2.01M |
Net income from continuing operations | -603.12%-10.67M | -99.15%-3.14M | -4.91%-1.78M | 49.48%-6.67M | 33.77%-1.87M | -13.43%-1.52M | 40.19%-1.58M | 73.40%-1.7M | -374.42%-13.19M | -51.26%-2.82M |
Operating gains losses | -319.74%-366.1K | -73.53%94.35K | 152.49%61.62K | -94.73%76.76K | 35.24%-328.95K | --166.61K | --356.5K | -105.98%-117.4K | 184.34%1.46M | -196.98%-507.93K |
Depreciation and amortization | 191.80%118.48K | 172.54%110.66K | 182.17%114.57K | 29.97%162.87K | 206.46%41.06K | -61.89%40.6K | 91.92%40.6K | 12.21%40.6K | 88.88%125.31K | -272.59%-38.57K |
Asset impairment expenditure | ---- | ---- | ---- | --856.29K | ---- | ---- | ---- | ---- | --0 | ---- |
Unrealized gains and losses of investment securities | --0 | --0 | --0 | ---- | ---- | -200.21%-21.17K | ---65.81K | --48.76K | ---- | ---- |
Remuneration paid in stock | 2,267.21%9.39M | 743.81%1.32M | -36.37%522.86K | -77.27%1.42M | -116.53%-42.36K | -0.22%396.66K | -88.49%156K | -77.19%821.74K | 996.29%6.23M | -32.84%256.23K |
Other non cashItems | ---76.02K | 91.87%-74.52K | -107.61%-73.05K | -95.29%47.62K | --3.95K | ---- | ---916.12K | --959.8K | --1.01M | ---- |
Change In working capital | -504.92%-1.02M | -35.04%677.63K | 199.06%891.51K | 5,492.36%1.24M | 742.33%934.39K | -56.36%250.89K | 2,355.31%1.04M | 18.06%-900K | -102.99%-23.06K | -75.48%110.93K |
-Change in receivables | ---- | -113.69%-23.76K | --0 | ---- | ---- | ---- | --173.57K | ---173.57K | ---- | ---- |
-Change in prepaid assets | -104.62%-295 | -126.43%-1.85K | -98.39%358 | 136.10%35.92K | -99.50%373 | -83.08%6.38K | 104.05%6.98K | 155.74%22.18K | -220.95%-99.49K | 364.47%75.01K |
-Change in payables and accrued expense | -520.07%-1.04M | -0.00%598.92K | 300.90%995.47K | 204.28%793.41K | 441.38%527.46K | -49.90%247.42K | 201.89%598.94K | 21.58%-495.52K | -72.15%260.75K | -78.09%97.43K |
-Change in other current assets | --0 | -53.75%104.32K | 51.49%-104.32K | 404.49%445.34K | 760.92%406.55K | -36.96%28.26K | 1,408.49%225.55K | 0.00%-215.03K | ---146.26K | ---61.51K |
-Change in other working capital | ---- | ---- | ---- | 18.08%-31.18K | --0 | -1,913.11%-31.18K | ---- | 82.01%-38.07K | -154.97%-38.07K | --0 |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -283.34%-2.62M | -5.58%-1.02M | 68.48%-267.1K | 34.82%-2.86M | 81.78%-366.59K | -187.26%-684.54K | 20.93%-963.1K | 55.19%-847.52K | -408.78%-4.39M | -285.46%-2.01M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0 | 0 | 0 | -216.67%-363.36K | 2,269.74%500.04K | |||||
Net PPE purchase and sale | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- | -2,080.91%-363.36K | --108.36K |
Net intangibles purchas and sale | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- | -216.67%-363.36K | 2,269.74%500.04K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 64.94%4.69M | 258.84%1.12M | -65.43%163.12K | -65.81%1.99M | -165.56%-1.64M | 3,140.99%2.85M | -78.94%311.01K | -82.70%471.9K | 485.57%5.81M | 4,069.61%2.51M |
Net issuance payments of debt | -98.45%2.89K | 50,100.00%40K | --163.12K | --0 | -98.00%7.68K | 154.22%186.8K | -100.01%-80 | --0 | 400.25%348.88K | 571.71%383.22K |
Net common stock issuance | --0 | 1,212.75%1.26M | --0 | -38.86%1.49M | -182.19%-1.59M | --2.49M | -2,583.19%-113.66K | 0.00%563.16K | 120.14%2.44M | 4,093.27%1.94M |
Proceeds from stock option exercised by employees | 19,768.06%4.58M | --0 | --0 | -84.05%494.04K | --0 | -23.21%23.04K | -13.76%458.75K | -99.45%12.25K | --3.1M | --293.72K |
Net other financing activities | -23.92%114.12K | ---- | ---- | ---- | ---- | -32.10%150K | 2,607.27%529.16K | -1,381.12%-666.67K | ---78.13K | ---109.93K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 64.94%4.69M | 27.67%1.12M | 278.75%163.12K | -65.81%1.99M | -165.56%-1.64M | 3,140.99%2.85M | -40.80%874.17K | -103.34%-91.26K | 485.57%5.81M | 4,069.61%2.51M |
Net cash flow | ||||||||||
Beginning cash position | 273.71%200.26K | -29.05%101.11K | -81.03%205.09K | 3,868.19%1.08M | 2,459.51%2.21M | -91.62%53.59K | -83.01%142.51K | 3,868.19%1.08M | 107.82%27.25K | -86.38%86.53K |
Current changes in cash | -4.62%2.06M | 211.49%99.15K | 88.92%-103.98K | -183.13%-876.21K | -302.02%-2.01M | 490.82%2.16M | 55.38%-88.93K | -226.68%-938.78K | 7,355.92%1.05M | 263.60%994.76K |
End cash Position | 2.12%2.26M | 273.71%200.26K | -29.05%101.11K | -81.03%205.09K | -81.03%205.09K | 2,459.51%2.21M | -91.62%53.59K | -81.45%142.51K | 3,868.19%1.08M | 3,868.19%1.08M |
Free cash from | -284.56%-2.63M | -5.58%-1.02M | 68.48%-267.1K | 39.80%-2.86M | 75.75%-366.59K | -49.00%-684.54K | 42.53%-963.1K | 57.36%-847.52K | -386.24%-4.75M | -177.39%-1.51M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.